NCT04803292

Brief Summary

The investigators design a retrospective, observational cohort study to provide contemporary information on the prevalence, characteristics, risk stratification,cost-effective, treatments and prognosis of Chinese hospitalized adult patients with intracerebral hemorrhage.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
10,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2012

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2012

Completed
9.2 years until next milestone

First Submitted

Initial submission to the registry

March 16, 2021

Completed
1 day until next milestone

First Posted

Study publicly available on registry

March 17, 2021

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2021

Completed
4 years until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2025

Completed
Last Updated

March 17, 2021

Status Verified

February 1, 2021

Enrollment Period

9.8 years

First QC Date

March 16, 2021

Last Update Submit

March 16, 2021

Conditions

Keywords

primary intracerebral hemorrhagehypertensionperihematomal edemasecondary brain injuryremote diffusion-weighted imaging lesions(R-DWILs)immune responsemultimodel imagecohortMRI

Outcome Measures

Primary Outcomes (1)

  • proportion of patients with a 3-month modified Rankin Scale (mRS) score≤ 3 proportion of patients with a 3-month modified Rankin Scale (mRS) score≤ 3 proportion of patients with a 3-month modified Rankin Scale (mRS) score≤ 3

    mRS 0-6, higher indicate worse outcome

    2-3years

Secondary Outcomes (3)

  • Absolute peripheral hematoma edema(PHE) growth

    2-3years

  • Relative peripheral hematoma edema(rPHE)

    2-3years

  • National institute of health stroke scale(NIHSS score)

    2-3years

Study Arms (3)

Second Affiliated Hospital, School of Medicine, Zhejiang University

a prospective cohort of patients of primary intracerebral hemorrhage in Second Affiliated Hospital, School of Medicine, Zhejiang University

Second People's Hospital of Hangzhou City, Zhejiang Province

a prospective cohort of patients of primary intracerebral hemorrhage in Second People's Hospital of Hangzhou City, Zhejiang Province

4th Affiliated Hospital, School of Medicine at Zhejiang University

a prospective cohort of patients of primary intracerebral hemorrhage in 4th Affiliated Hospital, School of Medicine at Zhejiang University

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Hospitalized patients over 18 years old with primary intrcerebral hemorrhage will be enrolled consecutively.

You may qualify if:

  • Hospitalized patients over 18 years old of primary intracerebral hemorrhage.

You may not qualify if:

  • patients of secondary intracerebral hemorrhage,such as hemorrhagic transformation of ischemic stroke, aneurysmal, cavernomas, arterio- venous malformations, central venous thrombosis, trauma-related, or tumor
  • isolated intraventricular hemorrhage or subarachnoid hemorrhage pregnant patients
  • unavailability to get complete blood cell samples and presenting contraindications or refusal to MRI
  • patients cannot be followed up for any reasons.
  • patients death in 24 hours
  • pregnant patients
  • surgical evacuation of hematoma

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

2nd Affiliated Hospital, School of Medicine at Zhejiang University

Hangzhou, Zhejiang, 310000, China

RECRUITING

Related Publications (3)

  • Jin Y, Huang YH, Chen YP, Zhang YD, Li J, Yang KC, Ye X, Jin LH, Wu J, Yuan CZ, Gao F, Tong LS. Combined effect of cortical superficial siderosis and cerebral microbleed on short-term and long-term outcomes after intracerebral haemorrhage. Stroke Vasc Neurol. 2024 Aug 27;9(4):429-438. doi: 10.1136/svn-2023-002439.

  • Jin YJ, Li JW, Wu J, Huang YH, Yang KC, An HN, Yuan CZ, Gao F, Tong LS. Cortical superficial siderosis, hematoma volume, and outcomes after intracerebral hemorrhage: a mediation analysis. Front Neurol. 2023 May 5;14:1122744. doi: 10.3389/fneur.2023.1122744. eCollection 2023.

  • Li J, Shen D, Zhou Y, Jin Y, Jin L, Ye X, Tong L, Gao F. Underlying microangiopathy and functional outcome of simultaneous multiple intracerebral hemorrhage. Front Aging Neurosci. 2022 Nov 8;14:1000573. doi: 10.3389/fnagi.2022.1000573. eCollection 2022.

Biospecimen

Retention: SAMPLES WITH DNA

Peripheral blood

MeSH Terms

Conditions

Cerebral HemorrhageHypertension

Condition Hierarchy (Ancestors)

Intracranial HemorrhagesCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesHemorrhagePathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Feng Gao, MD,PhD

    Second Affiliated Hospital, School of Medicine, Zhejiang University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Feng Gao, MD,PhD

CONTACT

Lusha Tong, MD,PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 16, 2021

First Posted

March 17, 2021

Study Start

January 1, 2012

Primary Completion

October 1, 2021

Study Completion

October 1, 2025

Last Updated

March 17, 2021

Record last verified: 2021-02

Locations